Daniel Finke
Daniel Finke publishes mostly in Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology, on topics such as Chemotherapy-induced cardiotoxicity and mitigation, Acute Myocardial Infarction Research and Peptidase Inhibition and Analysis.
- World rank
- #1,079,225 of 7,710,434 ranked researchers
- Rank in Germany
- #53,111 of 364,343
- Works
- 54
- Citations
- 1.1k
- Citations per work
- 20.9
What does Daniel Finke research?
Daniel Finke's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3666.1%
- Medicine3666.1%
- Everything else917.0%
- Life Sciences916.9%
- 1Cardiology and Cardiovascular Medicine36% of their works
- 2Molecular Biology17% of their works
- 3Oncology16% of their works
- 4Surgery7% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Public Health, Environmental and Occupational Health3% of their works
Research topics
- Chemotherapy-induced cardiotoxicity and mitigation
- Acute Myocardial Infarction Research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Cardiac Fibrosis and Remodeling
- Cardiac Structural Anomalies and Repair
- Viral Infections and Immunology Research
- Histone Deacetylase Inhibitors Research
Which keywords describe Daniel Finke's research?
The keywords of their largest research topics: Myocardial Infarction, Anthracyclines, Doxorubicin, Tumor Microenvironment, Cancer Therapy, Heart Failure, Acute Coronary Syndromes and Fibroblast Activation Protein.
- Histone Deacetylases
- Viral Infection
- Ventricular Reconstruction
- Inflammatory Response
- ST-Segment Elevation
- Immunosuppression
- Fibroblast Activation Protein
- Heart Failure
- Tumor Microenvironment
- Anthracyclines
- Myocardial Infarction
- Doxorubicin
- Cancer Therapy
- Acute Coronary Syndromes
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Cardiac Remodeling
- Surgical Repair
- Myocarditis
- HDAC Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Myocardial Infarction213 topics
- Anthracyclines181 topic
- Doxorubicin181 topic
- Tumor Microenvironment182 topics
- Cancer Therapy132 topics
- Heart Failure112 topics
- Acute Coronary Syndromes91 topic
- Fibroblast Activation Protein91 topic
- Immune Checkpoint Blockade91 topic
- Immunosuppression91 topic
- PD-1 and PD-L191 topic
- ST-Segment Elevation91 topic
- Cardiac Remodeling61 topic
- Inflammatory Response61 topic
- Surgical Repair61 topic
- Ventricular Reconstruction61 topic
- Myocarditis51 topic
- Viral Infection51 topic
- HDAC Inhibitors41 topic
- Histone Deacetylases41 topic
Where does Daniel Finke work?
Daniel Finke's main affiliation in the publication record is Heidelberg University, Germany.
How many publications and citations does Daniel Finke have?
OpenAlex counts 54 works and 1,129 citations for Daniel Finke, an h-index of 18, ranking #1,079,225 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Daniel Finke
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel Finke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.